The Saskatchewan government says this week’s shipment of 74,880 Pfizer COVID-19 vaccine doses is scheduled to arrive Wednesday in the province.
Those doses will be allocated between Regina, Saskatoon, Prince Albert, North Battleford, Indigenous Services Canada (ISC) North, ISC South, ISC North Battleford, Northern Inter-Tribal Health Authority Prince Albert and pharmacies throughout the province.
Wednesday also sees residents 65 and older become eligible to book an appointment for their second dose of the vaccine. Eligibility also includes anyone who received their first dose before March 22, 2021.
“Eligibility to book for second doses is based on age or date of first dose. Residents who meet at least one of these criteria are eligible for their second dose,” reads the government’s statement.
The province is also reporting one new COVID-19 death, 130 new cases and 116 more recoveries on Wednesday. The one death was reported in the 70 to 79 age group from the North West zone.
New cases per zone have been located in the Far North West, 8; North West, 13; North Central, 8; North East, 7; Saskatoon, 46; Central West, 1; Central East, 2; Regina, 22; South West, 2; South Central, 12; and South East, 7.
Active cases are at 1,285 cases with the seven-day average of new COVID-19 case number at 131 or 10.7 per 100,000 population.
There are 103 hospitalizations in Saskatchewan including 81 people receiving inpatient care and 22 people in ICUs.
As of Tuesday, 10,812 variants of concern have been identified by screening in Saskatchewan, reported in the following zones: Far North West, 244; Far North East, 46; North West, 609; North Central, 475; North East, 60; Saskatoon, 1,700; Central West, 109; Central East, 597; Regina, 4,670; South West, 381; South Central, 778; and South East, 1,077.
There were 81 new lineage results recorded on Wednesday. Of the 5,794 VOCs with lineages identified by whole genome sequencing in Saskatchewan, 5,594 are B.1.1.1.7 (UK), 159 are P.1 (Brazilian), 31 are B.1.617 (Indian) and 10 are B.1.351 (SA).
